Concepedia

N. Morellato

NM

Statistics

Publications

4

Citations

47

H-Index

4

Active since

2013

Affiliations

University of Padua(Current)

Istituto di Chimica Biomolecolare

Helmholtz-Zentrum Dresden-Rossendorf

Institute of Condensed Matter Chemistry and Technologies for Energy

N. Morellato is an author at University of Padua specializing in radiotracer development, radionuclide therapy, and radiopharmaceuticals.

Publications per year

2013–2016

4

Publications

4

99mTc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study

Cristina Bolzati, Davide Carta, Valentina Gandin et al. · JBIC Journal of Biological Inorganic Chemistry · 2013 · 13 citations

Medicine, Nuclear Medicine, Pharmacology +9

Synthesis and Characterization of [M<sup>III</sup>(PS)<sub>2</sub>(L)] Mixed-Ligand Compounds (M = Re, <sup>99</sup>Tc; PS = Phosphinothiolate; L = Dithiocarbamate) as Potential Models for the Development of New Agents for SPECT Imaging and Radiotherapy

Nicola Salvarese, N. Morellato, Alfonso Venzo et al. · Inorganic Chemistry · 2013 · 13 citations

Natural Sciences, Chemistry, Medicinal Chemistry +16

Assessment of the best N3− donors in preparation of [M(N)(PNP)]-based (M=99mTc-; 188Re) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG600-DTCZ)

Davide Carta, Christian Jentschel, Stefan Felix Thieme et al. · Nuclear Medicine and Biology · 2014 · 11 citations

Medicine, Nuclear Medicine, Pharmaceutics +12

Melanoma targeting with [ 99m Tc(N)(PNP3)]-labeled α-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties

Davide Carta, Nicola Salvarese, N. Morellato et al. · Nuclear Medicine and Biology · 2016 · 10 citations

Medicine, Oncology, Pharmacology +14

1–4 of 4